FMV Buys Malacca Property to Build Integrated Healthcare Hub
Real Estate

FMV Buys Malacca Property to Build Integrated Healthcare Hub

Fischer Medical Ventures, a leading medical device company listed on the Bombay Stock Exchange, is pleased to announce the successful acquisition of a landmark mixed-use property in Malacca, Malaysia. Strategically located next to the renowned Mahkota Hospital, the property comprises hotel, commercial, and retail components, and will serve as the foundation for FMV’s regional healthcare hub.

This acquisition represents a key milestone in FMV’s strategic growth plan to expand its presence across the healthcare value chain. FMV intends to progressively redevelop portions of the property into integrated healthcare facilities, including health screening centers, specialist clinics, and medical suites. The development will also serve as a direct channel to showcase and distribute FMV’s advanced medical device solutions to healthcare providers and patients.

Chairman of FMV, Ravindran Govindan, commented, “This acquisition is a strategic milestone for FMV. The property’s location—adjacent to Mahkota Hospital in a high-traffic, medically vibrant area—offers us a unique opportunity to reimagine healthcare access in the region. By integrating our innovative medical technologies directly into care environments, we are not only expanding our business reach but also contributing meaningfully to better patient outcomes.”

“This investment supports our broader vision to develop healthcare-enabled real estate assets in key regional centres across Southeast Asia. Malacca, with its strong medical tourism ecosystem and connectivity to Singapore, Indonesia and Philippines, is the ideal starting point,” he added.

The development aligns with FMV’s vision to create sustainable healthcare infrastructure that supports both clinical excellence and commercial scalability. It also serves as a platform for FMV to directly engage with healthcare professionals, patients, and institutional partners in a dynamic setting—accelerating product adoption, training, and after-sales support

The company expects the first phase of redevelopment to commence later this year, subject to regulatory approvals and planning. FMV will work closely with local authorities, medical stakeholders, and international partners to ensure the facility complements Malacca’s role as a key medical tourism destination.

Fischer Medical Ventures, a leading medical device company listed on the Bombay Stock Exchange, is pleased to announce the successful acquisition of a landmark mixed-use property in Malacca, Malaysia. Strategically located next to the renowned Mahkota Hospital, the property comprises hotel, commercial, and retail components, and will serve as the foundation for FMV’s regional healthcare hub.This acquisition represents a key milestone in FMV’s strategic growth plan to expand its presence across the healthcare value chain. FMV intends to progressively redevelop portions of the property into integrated healthcare facilities, including health screening centers, specialist clinics, and medical suites. The development will also serve as a direct channel to showcase and distribute FMV’s advanced medical device solutions to healthcare providers and patients.Chairman of FMV, Ravindran Govindan, commented, “This acquisition is a strategic milestone for FMV. The property’s location—adjacent to Mahkota Hospital in a high-traffic, medically vibrant area—offers us a unique opportunity to reimagine healthcare access in the region. By integrating our innovative medical technologies directly into care environments, we are not only expanding our business reach but also contributing meaningfully to better patient outcomes.”“This investment supports our broader vision to develop healthcare-enabled real estate assets in key regional centres across Southeast Asia. Malacca, with its strong medical tourism ecosystem and connectivity to Singapore, Indonesia and Philippines, is the ideal starting point,” he added.The development aligns with FMV’s vision to create sustainable healthcare infrastructure that supports both clinical excellence and commercial scalability. It also serves as a platform for FMV to directly engage with healthcare professionals, patients, and institutional partners in a dynamic setting—accelerating product adoption, training, and after-sales supportThe company expects the first phase of redevelopment to commence later this year, subject to regulatory approvals and planning. FMV will work closely with local authorities, medical stakeholders, and international partners to ensure the facility complements Malacca’s role as a key medical tourism destination.

Next Story
Technology

Building Faster, Smarter, and Greener!

Backed by ULCCS’s century-old legacy, U-Sphere combines technology, modular design and sustainable practices to deliver faster and more efficient projects. In an interaction with CW, Rohit Prabhakar, Director - Business Development, shares how the company’s integrated model of ‘Speed-Build’, ‘Smart-Build’ and ‘Sustain-Build’ is redefining construction efficiency, quality and environmental responsibility in India.U-Sphere positions itself at the intersection of speed, sustainability and smart design. How does this translate into measurable efficiency on the ground?At U..

Next Story
Infrastructure Transport

Smart Roads, Smarter India

India’s infrastructure boom is not only about laying more kilometres of highways – it’s about building them smarter, safer and more sustainably. From drones mapping fragile Himalayan slopes to 3D machine-controlled graders reducing human error, technology is steadily reshaping the way projects are planned and executed. Yet, the journey towards digitisation remains complex, demanding not just capital but also coordination, training and vision.Until recently, engineers largely depended on Survey of India toposheets and traditional survey methods like total stations or DGPS to prepare detai..

Next Story
Real Estate

What Does DCPR 2034 Mean?

The Maharashtra government has eased approval norms for high-rise buildings under DCPR 2034, enabling the municipal commissioner to sanction projects up to 180 m on large plots. This change is expected to streamline approvals, reduce procedural delays and accelerate redevelopment, drawing reactions from developers, planners and industry experts about its implications for Mumbai’s vertical growth.Under the revised DCPR 2034 rules, buildings on plots of 2,000 sq m or more can now be approved up to 180 m by the municipal commissioner, provided structural and geotechnical reports are certified b..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?